Lomefloxacinum [Latin] en es it fr

Lomefloxacinum [Latin] Brand names, Lomefloxacinum [Latin] Analogs

Lomefloxacinum [Latin] Brand Names Mixture

  • No information avaliable

Lomefloxacinum [Latin] Chemical_Formula


Lomefloxacinum [Latin] RX_link


Lomefloxacinum [Latin] fda sheet

Lomefloxacinum [Latin] msds (material safety sheet)

Lomefloxacinum_[Latin] MSDS

Lomefloxacinum [Latin] Synthesis Reference

No information avaliable

Lomefloxacinum [Latin] Molecular Weight

182.172 g/mol

Lomefloxacinum [Latin] Melting Point

168 oC

Lomefloxacinum [Latin] H2O Solubility

216 mg/mL

Lomefloxacinum [Latin] State


Lomefloxacinum [Latin] LogP


Lomefloxacinum [Latin] Dosage Forms

Liquid; Powder for solution; Solution

Lomefloxacinum [Latin] Indication

Used for the promotion of diuresis before irreversible renal failure becomes established; The reduction of intracranial pressure, the treatment of cerebral edema, and the promotion of urinary excretion of toxic substances.

Lomefloxacinum [Latin] Pharmacology

Chemically, mannitol is an alcohol and a sugar, or a polyol; it is similar to xylitol or sorbitol. However, mannitol has a tendency to lose a hydrogen ion in aqueous solutions, which causes the solution to become acidic. For this reason, it is not uncommon to add a substance to adjust its pH, such as sodium bicarbonate. Mannitol is commonly used to increase urine production (diuretic). It is also used to treat or prevent medical conditions that are caused by an increase in body fluids/water (e.g., cerebral edema, glaucoma, kidney failure). Mannitol is frequently given along with other diuretics (e.g., furosemide, chlorothiazide) and/or IV fluid replacement.

Lomefloxacinum [Latin] Absorption

Approximately 7% of ingested mannitol is absorbed during gastrointestinal perfusion in uremic patients.

Lomefloxacinum [Latin] side effects and Toxicity

LD50=1700 mg/kg (rat oral)

Lomefloxacinum [Latin] Patient Information

Lomefloxacinum [Latin] Organisms Affected

Humans and other mammals